Abstract:149 Background: Microsatellite instability (MSI) plays a crucial role as a cancer immunotherapy and prognosis biomarker, making accurate MSI detection essential. However, currently, there is still a lack of available data on the impact of neoadjuvant therapy on MSI status, as well as validated data on standardized methods for MSI testing in small biopsy samples. The study aimed to investigate the concordance of MSI status between paired biopsy and surgical samples, as well as the impact of neoadjuvant therapy on MSI status using a novel MSI next-generation sequencing (MSI-NGS) detection panel. Methods: A total of 137 colorectal cancer (CRC) patients were enrolled for this study, of whom 116 with paired biopsy and surgical samples were analyzed. A custom MSI-NGS panel was employed and its performance was compared to MSI polymerase chain reaction (MSI-PCR), which served as the gold standard. Results: Out of the 116 cases, 112 patients showed consistent MSI status between biopsy and surgical samples, with an overall accuracy of 97% regardless of the detection method used. In the cases with MSI discrepancy (6 cases), 83% (5/6) of the patients showed a transition from MSS to MSI-H from biopsy to surgery. Interestingly, all eight patients who received neoadjuvant chemotherapy maintained an unchanged MSI status. However, in one patient who received adjuvant treatment and underwent a repeat biopsy after surgery, the MSI status exhibited alterations. Further analysis of clonal evolution revealed that this heterogeneity stemmed from the disappearance of the original clones and the emergence of new clones. Additionally, the NGS panel exhibited strong concordance with MSI-PCR and high accuracy, sensitivity and specificity with an AUC of 0.942 after rigorous validation. Conclusions: The study revealed a high concordance in MSI status between paired biopsy and surgical samples by employing a custom MSI-NGS panel for MSI status detection, providing reliable basis for further research in this field. Moreover, neoadjuvant chemotherapy seemed to have no impact on MSI status in our study, whereas postoperative adjuvant chemotherapy may influence changes in MSI status, highlighting the necessity of reevaluating MSI status after surgery. The findings also underscore the potential of NGS-based MSI detection as a valuable tool for clinical decision-making.

Comparison of Microsatellite Instability With Clinicopathologic Data in Patients With Colon Adenocarcinoma

The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in Colorectal Adenocarcinoma

Microsatellite instability in sporadic colorectal cancer and its relationship with clinicopathological features

Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer

A Prospective Blinded Study of Microsatellite Instability (msi) As A Marker of Overall Survival (os) in the Adjuvant Treatment of Colorectal Cancer (crc) Patients.

Comparison of histopathologic and clinical characteristics of microsatellite instability in colorectal adenocarcinomas and its impact on survival

Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature

Microsatellite Instability in Sporadic Multiple Primary Colorectal Carcinoma

Association of Microsatellite Instability and Gene Expression Profile in Colorectal Carcinoma and Potential Implications for Therapy

Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients.

Microsatellite Instability Testing and Prognostic Implications in Colorectal Cancer

Correlation between mismatch repair statuses and the prognosis of stage I–IV colorectal cancer

Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives.

Microsatellite instability in sporadic and inherited colon adenocarcinomas from Greek patients: correlation with several clinicopathological characteristics

The Mutational Landscape of MSI-H and MSS Colorectal Cancer.

Microsatellite Instability of Sporadic Colorectal Carcinomas and Its Clinicopathological Significance

Clinical, pathological, and adjuvant chemotherapy use differences among microsatellite unstable and microsatellite stable colon cancers

Consistency and heterogeneity of microsatellite instability (MSI) status in paired biopsy and surgical specimens of colorectal cancer: A necessity for MSI reassessment after treatment?

Status and Clinical Value of Microsatellite Instability in Stage Ⅱ Colon Cancer

Association between microsatellite instability status, clinicopathological features and mitochondrial DNA amplification in patients with colorectal cancer

Reduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer